American Cancer Society. (2010, December 16). Breast Cancer in Men. Atlanta, GA: American Cancer Society.
12: Cancer of the male breast. BC Cancer Agency. (2004, November). Cancer Management Guidelines. Vancouver, BC: BC Cancer Agency.
Brinton LA, Richesson DA, Gierach GL, et al. Prospective evaluation of risk factors for male breast cancer. (2008, October 15). Journal of the National Cancer Institute. Oxford University Press. 100(20):1477-81. Epub 2008 Oct 7 (PMID: 18840816).
Burstein, H.J., Harris, J.R., & Morrow, M. Cancer of the Breast: Section 2: Malignant Tumors of the Breast. Devita, V. T., Jr., Lawrence, T. S., & Rosenberg, S. A. (2008). Cancer: Principles & Practice of Oncology. (8th Édition). Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins. 43(2) pp. 1606-1654.
Cancer Care Ontario. Drug Formulary. Toronto, ON: Cancer Care Ontario.
Cutuli B, Le-Nir CC, Serin D, et al. Male breast cancer. Evolution of treatment and prognostic factors. Analysis of 489 cases. (2010, March). Critical Reviews in Oncology/Hematology. Elsevier. 73(3):246-54. Epub 2009 May 12 (PMID: 19442535).
Doyen J, Italiano A, Largillier R, et al. Aromatase inhibition in male breast cancer patients: biological and clinical implications. (2010, June). Annals of Oncology. Oxford Journals. 21(6):1243-5. Epub 2009 Oct 27 (PMID: 19861576).
Hayes TG. Pharmacologic treatment of male breast cancer. (2009, October). Expert Opinion in Pharmacotherapy. Informa Healthcare. 10(15):2499-510 (PMID: 19708850).
Breast cancer in men. Macmillan Cancer Support. (2010, April). Macmillan Cancer Support. London, UK: Macmillan Cancer Support.
The risk of male breast cancer with finasteride. Medicines and Healthcare Products Regulatory Agency. (2009, December). MHRA Public Assessment Report.
Miller, K. D., & Sledge Jr., G. W. Male breast cancer. Raghavan, E., Brecher, M. L., Johnson, D. H., et al. (Eds.). (1999). Textbook of Uncommon Cancer. (2nd Édition). Chichester: John Wiley & Sons. 63: pp. 733-738.
National Cancer Institute. (2010, July 8). Male Breast Cancer Treatment (PDQ®) Health Professional Version. Bethesda, MD: National Cancer Institute.
Visram H, Kanji F, Dent SF. Endocrine therapy for male breast cancer: rates of toxicity and adherence. (2010, October). Current Oncology. Toronto, ON: Multimed Inc. 17(5):17-21 (PMID: 20975874).×